Coloplast A/S

Equities

COLO B

DK0060448595

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Copenhagen Other stock markets 16:20:00 06/09/2024 BST			5-day change	1st Jan Change
916.80 ^DKK	+2.37%		-0.37%	+18.76%

08-26	COLOPLAST : Q3 24: Chronic care momentum makes up for urology pain
08-21	Jyske Bank Downgrades Coloplast to Hold, Trims PT	MT

Coloplast A/S Announces Interim Dividend for the First Half of 2023/24, Payable on May 15, 2024

May 07, 2024 at 06:00 am

Coloplast A/S will pay half-year interim dividend of DKK 5.00 per share for the first half of 2023/24, for a total dividend pay-out of DKK 1,125 million. Ex-dividend date is May 13, 2024. Values is May 14, 2024.

Disbursement date is May 15, 2024.

Latest news about Coloplast A/S

COLOPLAST : Q3 24: Chronic care momentum makes up for urology pain	08-26
Jyske Bank Downgrades Coloplast to Hold, Trims PT	08-21	MT
Global markets live: Rio Tinto, GSK, Palo Alto, GM, Lowe's...	08-20
Coloplast Sticks to 2024 Guidance as Fiscal Third Quarter Revenue Beats, Profit Misses	08-20	MT
Transcript : Coloplast A/S, Nine Months 2024 Earnings Call, Aug 20, 2024	08-20
Coloplast's Fiscal Q3 Net Profit Flatlines; Revenue Rises	08-20	MT
Coloplast A/S Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2024	08-20	CI
Coloplast A/S Re-Affirms Earnings Guidance for the Fiscal Year 2023/24	08-20	CI
Powell's Hint Hunt	08-19
AlphaValue/Baader Europe Downgrades Coloplast to Reduce, Trims PT	08-15	MT
Barclays Upgrades Coloplast to Overweight, Lifts PT	07-22	MT
Danske Bank Upgrades Coloplast to Buy from Hold	07-10	MT
Transcript : Coloplast A/S - Analyst/Investor Day	06-06
COLOPLAST : Multiple silver linings in spite of a soft Q2 24	05-15
European shares hit one-month high as earnings take centre stage	05-07	RE
European shares hit one-month high on upbeat earnings, rate-cut optimism	05-07	RE
Transcript : Coloplast A/S, H1 2024 Earnings Call, May 07, 2024	05-07
Coloplast Posts Higher Fiscal H1 Net Profit, Revenue	05-07	MT
Coloplast Strengthens Ostomy Care Portfolio with Three Significant Product Launches	05-07	CI
Coloplast A/S Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	05-07	CI
Coloplast A/S Revises Earnings Guidance for the Fiscal Year 2023/24	05-07	CI
Coloplast A/S Announces Interim Dividend for the First Half of 2023/24, Payable on May 15, 2024	05-07	CI
Certain B Shares of Coloplast A/S are subject to a Lock-Up Agreement Ending on 27-FEB-2024.	02-26	CI
COLOPLAST : Q1 24: Many more positives beyond the margin beat	02-14
Nordic Shares Moved Upward Friday; Kongsberg Gruppen Topped Leaders	02-09	DJ

Chart Coloplast A/S

Duration

Period

More charts

Company Profile

Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows: - hygiene products (43.4%): urine bags, plugs, urinary testing systems and sets, etc.; - ostomy care products (36.8%): bags and equipment used following intestinal operations; - wound care and skincare products (11.9%): wound dressings, bandages, creams and gels; - voice and respiratory care products (7.9%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc. Net sales are distributed geographically as follows: Denmark (1.4%), the United States (21%), the United Kingdom (14%), France (10.8%) and other (52.8%).

Employees

16,019

Sector

Medical Equipment, Supplies & Distribution

Calendar

05/11/2024 - Q4 2024 Earnings Release

Related indices

STOXX Europe 600 Index (EUR)

More about the company